Table 1.
Performance summary of TES and tunable NOT gate.
| Device | Design | Dynamic range (a.u.) | Fold change | Intersection | K range (RPU) | |||
|---|---|---|---|---|---|---|---|---|
| Low | High | Low | High | Low | High | |||
| TES | Original | 333 ± 53 | 877 ± 695 | 14 ± 1.7 | 2.4 ± 1.2 | 0.78 ± 0.06 | 0.69 ± 0.16 | – |
| sRNA booster | 538 ± 51 | 2064 ± 1070 | 227 ± 297 | 5.7 ± 1.8 | 0.46 ± 0.04 | 0.35 ± 0.15 | – | |
| Noninsulated | 882 ± 134 | 2149 ± 409 | 445 ± 412 | 31 ± 16 | 0.26 ± 0.07 | 0.27 ± 0.06 | – | |
| Combined | 1550 ± 209 | 1712 ± 584 | 1236 ± 613 | 66 ± 54 | 0.15 ± 0.04 | 0.22 ± 0.04 | – | |
| NOT gate | Original | 17280 ± 1273 | 3512 ± 286 | 6.0 ± 0.1 | 1.5 ± 0.1 | 0.19 ± 0.04 | 0.84 ± 0.02 | 0.01–0.07 |
| sRNA booster | 22040 ± 1601 | 2170 ± 654 | 5.8 ± 0.3 | 0.9 ± 0.3 | 0.13 ± 0.07 | 0.85 ± 0.02 | 0.01–0.06 | |
| Noninsulated | 17466 ± 1926 | 4061 ± 827 | 6.8 ± 0.3 | 2.6 ± 0.4 | 0.11 ± 0.03 | 0.56 ± 0.08 | 0.02–0.04 | |
| Combined | 27751 ± 3104 | 2383 ± 165 | 6.0 ± 0.6 | 0.9 ± 0.1 | 0.08 ± 0.05 | 0.90 ± 0.03 | 0.003–0.02 | |
Average values are shown ±1 standard deviation calculated from flow cytometry data for three biological replicates. The low and high columns correspond to experiments when the tuner promoter activity is 0.002 RPU and 2.61 RPU, respectively. Dynamic range is calculated as the absolute difference in YFP fluorescence between on and off inputs states. The on and off input states correspond to input promoter activities of 6.6 RPU and 0.002 RPU for the TES, and 1.5 RPU and 0.002 RPU for the NOT gate, respectively. Fold change is calculated for YFP fluorescence between on and off input states. Intersection is calculated as the fractional overlap between distributions for on and off input states. The K range gives the span of K values from Hill functions fitted to experimental data. The designs are as follows: original designs are the initial constructs (Figs. 1a and 2a), sRNA booster designs include the additional sRNA booster plasmid (Fig. 3c), the noninsulated designs have the RiboJ element removed (Fig. 4), and the combined designs have both RiboJ removed and the sRNA booster plasmid present.